Subscriptions are live: We're on the subscription model now, early-access price $24.99/month, with day, week, and longer plans too. New accounts start with 5 free premium days. Prefer to donate? Donations grant premium time and are logged on your profile page.

Plans & pricing
Donate for premium time
Logo
Sign In

$GCTK

GlucoTrack, Inc. Common Stock

XNAS•Health Care•Surgical & Medical Instruments & Apparatus

$0.5041-3.98%−$0.0209Prev $0.5250LIVE Full chart Live alerts
No recent price bars, the chart lights up when GCTK starts printing.

Why is GCTK down today? It is at $0.504 (-3.98%), and our scanner flagged it 146 times on unusual volume this month. See the catalyst behind the move, real-time alerts the moment GCTK spikes, and full due diligence on GCTK — key stats, earnings, dilution and insider activity. Free.

Free alerts

Get free $GCTK alerts the moment volume spikes

Our scanner flagged $GCTK 146 times in the last 30 days. Create a free account to track $GCTK, build a watchlist, and get instant unusual-volume alerts — plus 5 free premium days, no card needed.

Real-time RVOL & momentum alerts Personal watchlist & price alerts
Sign up free with email

No card · 5 premium days · join 800+ traders

Key Stats

Price & performance
Price
$0.504
Change today
-3.98%
Previous close
$0.525
52-week range
$0.250 – $14.14
Valuation & dividend
Market cap
$3M
Ownership & volume
Shares outstanding
7.7M
Live vendor count ↗
Institutional own.
3.01%
Total held
3.0%
Tradeable float
7.5M
97% of shares · after 3% institutions
Short interest
2.4M
▲ +368% vs prior · as of 2026-07-15
Short % of float
31.9%
Days to cover
1.0d
Avg daily volume
4.3M
Next earnings
Aug 13 · in 7d
Classification
Sector
Health Care
Industry
Surgical & Medical Instruments & Apparatus
Exchange
XNAS
Relative volumevs this time of day
5m
0.0x
15m
0.0x
1h
0.0x
1D
0.9x

Get free GCTK + market alerts in your inbox

The top plays and unusual-volume catches our scanner flags, emailed to you. No account needed.

No spam. Unsubscribe anytime. Not investment advice.

Why is $GCTK down today?

SEC filing

Here is the latest on GCTK from our scanner (live price and day move above). Fresh from the SEC: Glucotrack, Inc.: $2.0 Million Equity Financing at $0.75 Per Unit, priced at a premium to the market, and $3.5 Million Follow-On Investment from Institutional. A material company disclosure like this is often the real catalyst behind a move of this size.

Likely catalyst$2.0 Million Equity Financing at $0.75 Per Unit, priced at a premium to the market, and $3.5 Million Follow-On Investment from InstitutionalReported Announces $5.5 Million FinancingReported today announced definitive agreements for approximately $5.5 million in financing from participating institutional investors, includingReported a $2.0 million equity financing priced at $0.75 per unit and a $3.5 million follow-on investment in the form of convertible debt., from the latest SEC filing. Read it →
Why is $GCTK moving? →▶ Replay the moveAuto-generated from live scanner data. Not investment advice.
Trading profile📅 Earnings in 7dLow float · 7.5M sh🔥 Heavily shorted · 32% of floatNot shortableSSR active · triggered Aug 05 (-20%)Borrow via Alpaca · SSR from Reg SHO 201

Insiders

0 buys, 0 sells last 3 months (3/0 over 12 months)
Show 10 recent transactions
InsiderActionShares% of positionOwns afterValueDate
Carter Erin Catherine
Director
Acquired (grant/award)+386added 22%2Kn/aOct 3, 25
Malave Luis
Director
Acquired (grant/award)+463added 13%4Kn/aOct 3, 25
Balo Andrew K
Director
Acquired (grant/award)+1K
0.02% of company
added 38%5Kn/aOct 3, 25
Carter Erin Catherine
Director
Acquired (grant/award)+1K
0.02% of company
added 100%2Kn/aJul 11, 25
Malave Luis
Director
Acquired (grant/award)+1K
0.02% of company
added 50%4Kn/aJul 11, 25
Balo Andrew K
Director
Acquired (grant/award)+3K
0.05% of company
added 100%3Kn/aJul 11, 25
Goode Paul
Officer
Acquired (grant/award)+42added 14%339n/aMar 25, 25
Carter Erin Catherine
Director
Acquired (grant/award)+32added 4.4%762n/aMar 25, 25
Malave Luis
Director
Acquired (grant/award)+35added 1.5%2Kn/aMar 25, 25
Balo Andrew K
Director
Acquired (grant/award)+75n/a75n/aMar 25, 25

Recent Form-4 filings via Nasdaq. Open-market buys are the signal worth watching. Grants and automatic (10b5-1) sells are routine. “% of position” is the share of that insider’s own holding the trade moved. Not investment advice.

$GCTK is down 4.0% today and has an active shelf on file. See who may be selling into moves →

Dilution watch

Active shelf

At-the-market (ATM) offering active — the company can keep selling new shares into the market over time (ongoing). If $GCTK runs, these filings show who may be positioned to sell new or newly-registered shares into the move.

Sourced from SEC EDGAR filings (last 9 months); terms read straight from the filing text where available. Ongoing = an at-the-market (ATM) program still selling over time or a live shelf, so it can keep diluting; Completed = a one-time priced sale that already finished. A shelf (S-3) stays effective ~3 years. Form type signals dilution capacity, not an exact share count, and we can't confirm how much of a shelf or ATM remains unused. Not investment advice.

$GCTK Sentiment

Bullish
Bearish67Bullish
📰 News: 4 bull · 0 bearToday: -4.0%👥 Community: 0 bull · 0 bear

Blend of news sentiment, today’s move, and community votes. Not investment advice.

$GCTK Activity

News, unusual-volume alerts, AI-trader trades and community chatter — the whole story, newest first.

News· SEC EDGAR· 18h ago
Glucotrack, Inc.: $2.0 Million Equity Financing at $0.75 Per Unit, priced at a premium to the market, and $3.5 Million Follow-On Investment from Institutional
Alert· 19h ago +3.3% vs EMA
GCTK 200EMA (15m) Trending · 52 bars · L3 · +3.29% above EMA · slope +2.18%
at $0.517
Alert· 20h ago
The Watcher SOLD $GCTK at $0.5504 __THOTH_JSON__{"side":"sell","strategyLabel":"The Watcher · scalp","reason":"level_fail","shares":23,"instance":"Rider"}
at $0.550
Alert· 20h ago
The Watcher BOUGHT $GCTK at $0.5552 __THOTH_JSON__{"side":"buy","strategyLabel":"The Watcher · scalp","reason":"scalp entry · coil-under9","shares":23,"instance":"Rider","setup":"coil-under9"}
at $0.555
Alert· 21h ago
The Watcher SOLD $GCTK at $0.5614 __THOTH_JSON__{"side":"sell","strategyLabel":"The Watcher · scalp","reason":"time_box","shares":54,"instance":"Rider"}
at $0.561
Alert· 22h ago
The Watcher BOUGHT $GCTK at $0.5680 __THOTH_JSON__{"side":"buy","strategyLabel":"The Watcher · scalp","reason":"scalp entry · support-reclaim","shares":54,"instance":"Rider","setup":"support-reclaim"}
at $0.568
Alert· 1d ago
The Watcher SOLD $GCTK at $0.5676 __THOTH_JSON__{"side":"sell","strategyLabel":"The Watcher · scalp","reason":"time_box","shares":63,"instance":"Rider"}
at $0.568
Alert· 1d ago +1.8% vs EMA
GCTK 50EMA (1m) Trending · 58 bars · L3 · +1.81% above EMA · slope +2.04%
at $0.581
Alert· 1d ago 6.0× RVOL
GCTK hit 5.973x RVOL at 11:12 AM ET
at $0.581
Alert· 1d ago
The Watcher SOLD $GCTK at $0.5468 __THOTH_JSON__{"side":"sell","strategyLabel":"The Watcher · scalp","reason":"reconcile_sync","shares":28,"instance":"Rider"}
at $0.547
Alert· 1d ago
The Watcher BOUGHT $GCTK at $0.5382 __THOTH_JSON__{"side":"buy","strategyLabel":"The Watcher · scalp","reason":"scalp entry · support-reclaim","shares":28,"instance":"Rider"}
at $0.538
Alert· 1d ago -2.7% vs EMA
$GCTK near 200 EMA: -2.72% from 200 EMA at 8:49 AM ET
at $0.529
Alert· 1d ago 5.6× RVOL
GCTK hit 5.608x RVOL at 8:49 AM ET
at $0.529
Alert· 1d ago +4.56%
$GCTK moved +4.56% in 1 min (Level 4) at 8:31 AM ET
at $0.580
Alert· 1d ago +4.54%
$GCTK moved +4.54% in 1 min (Level 4) at 7:56 PM ET
at $0.547
Alert· 1d ago 3.1× RVOL
GCTK hit 3.112x RVOL at 5:28 PM ET
at $0.617
Alert· 1d ago +9.34%
$GCTK moved +9.34% (~15m high-low range 9.34%) (Level 5) at 5:14 PM ET
at $0.539
Alert· 1d ago +16.8% vs EMA
GCTK 200EMA (5m) Trending · 51 bars · L3 · +16.79% above EMA · slope +6.74%
at $0.538
Alert· 1d ago +3.1% vs EMA
GCTK 200EMA (1m) Trending · 174 bars · L4 · +3.13% above EMA · slope +2.74%
at $0.523
Alert· 1d ago +4.5% vs EMA
GCTK 200EMA (1m) Trending · 173 bars · L4 · +4.50% above EMA · slope +3.02%
at $0.530
Alert· 1d ago +4.5% vs EMA
GCTK 200EMA (1m) Trending · 173 bars · L4 · +4.50% above EMA · slope +3.02%
at $0.530
Alert· 1d ago -5.77%
$GCTK moved -5.77% (~15m high-low range 5.77%) (Level 5) at 4:11 PM ET
at $0.520
Alert· 1d ago -1.90%
$GCTK moved -1.90% in 1 min (Level 1) at 3:59 PM ET
at $0.589
Alert· 1d ago 6.1× RVOL
GCTK hit 6.070x RVOL at 3:28 PM ET
at $0.643
Alert· 1d ago -13.01%
$GCTK moved -13.01% in 1 min (Level 1) at 3:12 PM ET
at $0.635
Alert· 1d ago
The Watcher SOLD $GCTK at $0.5920 __THOTH_JSON__{"side":"sell","strategyLabel":"The Watcher · day","reason":"wick_exit","shares":18,"instance":"Rider"}
at $0.592
News· SEC EDGAR· 6d ago
Glucotrack, Inc. filed an 8-K: Regulation FD Disclosure
News· SEC EDGAR· 7d ago
Glucotrack, Inc. filed an 8-K: Material Agreement, New Financial Obligation, Unregistered Share Sale
News· SEC EDGAR· 9d ago
Glucotrack, Inc. filed an 8-K: Material Agreement, New Financial Obligation, Unregistered Share Sale
News· GlobeNewswire Inc.· 19d ago Bullish
E.F. Hutton & Co. Serves as Exclusive Financial Advisor on Strategic Business Combination Between Glucotrack and Lōkahi Therapeutics and Exclusive Placement Agent for Approximately $5.7 Million Convertible Note Financing
News· GlobeNewswire Inc.· 20d ago Bullish
UPDATE – Glucotrack and Lōkahi Therapeutics Complete Strategic Business Combination, Establishing Lōkahi-Controlled Public Platform
News· GlobeNewswire Inc.· 83d ago Bullish
Glucotrack Reports First Quarter 2026 Financial Results and Recent Corporate Highlights
News· GlobeNewswire Inc.· 90d ago Bullish
Glucotrack Announces IDE Submission for U.S. Clinical Study of its Novel Implantable Continuous Blood Glucose Monitoring Technology

Related SURGICAL stocks

$SYK$MMM$BSX$BDX$RMD$DXCM$MDLN$WST

Also moving today

The tickers our scanner is lighting up most over the last 48 hours.

$BJDX$CELZ$ZETA$AMIX$APPS$FLNC$AXTX$SNDK$RITR$SSPC$AXTI$SPCX

GCTK stock FAQ

Why is $GCTK down today?

Here is the latest on GCTK from our scanner (live price and day move above). Fresh from the SEC: Glucotrack, Inc.: $2.0 Million Equity Financing at $0.75 Per Unit, priced at a premium to the market, and $3.5 Million Follow-On Investment from Institutional. A material company disclosure like this is often the real catalyst behind a move of this size.

What is the GCTK stock price today?

GCTK last traded at $0.504, down 3.98% on the day. The price and chart above update live during market hours (4 AM to 8 PM ET).

When does GCTK report earnings?

GlucoTrack, Inc. Common Stock (GCTK) is next expected to report earnings on Thursday, August 13, 2026, about 7 days away. Earnings reports often cause large overnight gaps, so many traders manage risk around the date. The date can shift until the company officially confirms it.

Where can I see live GCTK alerts?

The GCTK Live Alerts panel on this page streams real-time unusual volume (RVOL), momentum, halt and 200-EMA alerts from our scanner the moment they fire. Our scanner has flagged GCTK 146 times in the last 30 days.

What exchange is GCTK on?

GCTK (GlucoTrack, Inc. Common Stock) trades on XNAS, with a market cap of about $3M in the SURGICAL & MEDICAL INSTRUMENTS & APPARATUS sector.

Is GCTK good for day trading?

That depends on your strategy and risk. Day traders look for volume, volatility and a clear trend. Use the live chart, RVOL alerts and 200-EMA context on this page to judge GCTK for yourself. This is not investment advice.

Live data from TheDesperateTrader scanner. Not investment advice.